Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
04 August 2022 - 9:30PM
Business Wire
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital
therapeutics (PDT) company developing nutritional cognitive
behavioral therapy (nCBT) to address the root causes of
cardiometabolic diseases, today announced it will release its
second quarter 2022 financial results before the market opens on
Thursday, August 11, 2022. Management will host a conference call
and webcast to provide a business update at 8:30 a.m. ET / 5:30
a.m. PT on Thursday, August 11, 2022.
To access the conference call, please register at:
https://register.vevent.com/register/BI6da59cc90fdb42a39adb1f216262cac7.
Upon registering, each participant will be provided with call
details and access codes. All participants are encouraged to join
10 minutes prior to the start time. The live webcast may be
accessed by visiting the event link at:
https://edge.media-server.com/mmc/p/zcn84y83. Following the
webcast, a replay of the webcast may be accessed from the
Presentations & Events page in the Investors section of the
Better Therapeutics corporate website at:
investors.bettertx.com.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics (PDT)
company developing a novel form of cognitive behavioral therapy to
address the root causes of cardiometabolic diseases. The company
has developed a proprietary platform for the development of
FDA-regulated, software-based solutions for type 2 diabetes, heart
disease and other conditions. The cognitive behavioral therapy
delivered by Better Therapeutics’ PDT is designed to enable changes
in neural pathways of the brain so lasting changes in behavior
become possible. Addressing the underlying causes of these diseases
has the potential to dramatically improve patient health while
lowering healthcare costs. Better Therapeutics clinically validated
mobile applications are intended to be prescribed by physicians and
reimbursed like traditional medicines.
For more information visit: bettertx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220804005116/en/
Investor Relations: Mark Heinen IR@bettertx.com
Media: Ryan McKenna at Real Chemistry
rmckenna@realchemistry.com
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From Apr 2024 to May 2024
Better Therapeutics (NASDAQ:BTTX)
Historical Stock Chart
From May 2023 to May 2024